Clinical Trial

Response Evaluation of Cancer Therapeutics in Metastatic Castration-Resistant Prostate Cancer to the Bone

Study acronym: RESPECT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 20, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
This study is aimed to compare whole body MRI (WB-MRI) with Bone Scintigraphy (BS) and Computerized Tomography (CT) scans in patients receiving treatment for metastatic castration-resistant prostate cancer to the bone. This is a monocentric, prospective observational study.
Trial Details
NCT Number NCT06321679
Lead Sponsor European Institute of Oncology
Conditions Castration-resistant Prostate Cancer
Enrollment 40 participants
Start Date 2020-07-03
Primary Completion 2024-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-03-20